Cameron Joseph
Political Reporter and Editor at Freelance
Washington Bureau Senior Reporter at The Christian Science Monitor
Washington bureau senior reporter @csmonitor. Covering politics, policy & DC. Previous work in @guardian @latimes @cjr etc. @vicenews alum.
Articles
-
1 day ago |
spherixglobalinsights.com | Cameron Joseph
Following a period of stability in the US biologic asthma market, new data reveals hidden opportunities for differentiation and growing prescriber interest in emerging pipeline therapies Exton, PA, May 13, 2025 – Although no new biologics for asthma have been approved since the 2021 launch of Tezspire (Amgen/AstraZeneca), recent insights from Spherix Global Insights point to a market primed for innovation.
-
6 days ago |
csmonitor.com | Cameron Joseph
President Donald Trump and Salvadoran President Nayib Bukele were all smiles. The leader of the free world and the Central American leader who has described himself as the “world’s coolest dictator” sat in the Oval Office in mid-April, discussing their agreement to send hundreds of deported migrants to El Salvador’s notorious prison system.
-
6 days ago |
spherixglobalinsights.com | Cameron Joseph
Products such as Tarpeyo (Calliditas), Filspari (Travere) and now Novartis’ Fabhalta and Venrafia provide physicians more options than ever before. Exton, PA, May 8, 2025 – With multiple targeted therapies now available and SGLT2 inhibitors broadly embraced, nephrologists across the globe are redefining how they manage IgA Nephropathy (IgAN) patients.
-
1 week ago |
spherixglobalinsights.com | Cameron Joseph
US hematologists express growing confidence in curative gene therapies such as Casgevy and Lyfgenia, while also showing heightened enthusiasm for next-generation disease-modifying agents. Exton, PA, May 01, 2025 – Patients with sickle cell disease (SCD) continue to face severe complications, despite advances in treatment that have helped mitigate some risks.
-
2 weeks ago |
spherixglobalinsights.com | Cameron Joseph
The ACR’s updated lupus nephritis treatment guidelines emphasize triple therapy regimens anchored by Benlysta or a calcineurin inhibitor, while Gazyva’s potential role in the evolving landscape remains to be established as the field continues to advance.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 26K
- Tweets
- 34K
- DMs Open
- Yes
With Stephen Miller suggesting Trump might suspend habeas corpus and ICE arresting Newark Mayor Ras Baraka, reupping my magazine cover story that was published yesterday morning: https://t.co/bTaFFW6o9j
When Donna Brazile was just a bit older than Hogg 35 years ago she worked for Eleanor Holmes Norton... who is still in office.
David Hogg: "There've been a few members that have come out, that have said, 'if I retire my life is effectively over'... Get over yourself. This isn't about you." Donna Brazile: "I'm glad David is throwing a rock inside the party... I know what I did when I was his age, I https://t.co/HJLnUlM7Vp
RT @Bencjacobs: ‘If You Can Survive the Hill, You Can Survive in Prison’ https://t.co/ozZ5pa6qSy via @politico